Scientists in Sweden have created a new pill designed to help the body burn fat and control blood sugar in a different way than popular GLP-1 drugs, like Ozempic. While injectable GLP-1s work by ...

Each year, the FDA approves a wide range of medications that help shape the future of medicine in the U.S. These include novel drugs that offer new treatment options, as well as first generics and ...

An experimental combo drug from Novo Nordisk leads to more weight loss than semaglutide alone, according to late-stage trial ...

The Food and Drug Administration recently approved Belgium-based Janssen Pharmaceuticals’ drug Invokamet XR for first-line use to improve glycemic control in diabetic adults when paired with diet and ...

The drugs in development include a pill that a new trial suggests is about as effective as Ozempic. By Dani Blum Reporting from the American Diabetes Association Scientific Sessions in Chicago.

.

A protein that has long frustrated diabetes researchers is suddenly at the center of a very different fight. By targeting an enzyme called protein tyrosine phosphatase 1B, or PTP1B, scientists are ...

The American College of Lifestyle Medicine has published the first clinical practice guideline focusing primarily on lifestyle interventions for diabetes treatment and potential remission of type 2 ...

Common diabetes drugs may do more than regulate blood sugar—they could also influence how cancers grow, spread, or slow down. Researchers are now unraveling how these medications affect immune ...